In conclusion, our results suggest novel molecular mechanisms whereby MEOX2 and GLI-1 may modulate functional dynamics between cBAF (SMARCB1) and ncBAF (BRD9) complexes, contributing to lung cancer progression (Fig. 5C). Here, BRD9 is linked to lung cancer.